NINDSdirector Profile Banner
Walter J. Koroshetz Profile
Walter J. Koroshetz

@NINDSdirector

Followers
7K
Following
75
Media
511
Statuses
3K

Official Twitter account of NINDS Director Walter J. Koroshetz, M.D., part of @NIH. RTs are not endorsements. Privacy Policies: https://t.co/AlUPqyclot

Bethesda, MD
Joined January 2015
Don't wanna be here? Send us removal request.
@NINDSdirector
Walter J. Koroshetz
6 days
“Attending #SfN25? Stop by booth #3900 to connect with NINDS Program Directors and staff! We’ll be at the NIH exhibit booth to answer your questions and available for one-on-one meetings. Explore NINDS-related events and presentations happening all week: https://t.co/lOmn2urHs8“
Tweet card summary image
ninds.nih.gov
0
2
4
@NINDSdirector
Walter J. Koroshetz
6 days
“Attending #SfN25? Stop by booth #3900 to connect with NINDS Program Directors and staff! We’ll be at the NIH exhibit booth to answer your questions and available for one-on-one meetings. Explore NINDS-related events and presentations happening all week: https://t.co/lOmn2urHs8“
Tweet card summary image
ninds.nih.gov
0
2
4
@NINDSdirector
Walter J. Koroshetz
6 days
NIH looking to fill positions to Direct 14 of our Institutes and Centers. It's a once in a lifetime opportunity to advance science in your field on a national level.
@NIH
NIH
8 days
The NIH has additional opportunities available for exceptional senior-level candidates to lead Institutes and the Intramural Research Program within the NIH. These leadership roles provide overall executive direction and scientific leadership for the Institutes mission and
2
2
6
@NINDSdirector
Walter J. Koroshetz
2 months
NIH/NINDS-funded trial of ventricular shunting demonstrates clinical benefit in persons with normal pressure hydrocephalus (NPH). NPH is a reversible condition sometimes misdiagnosed as Alzheimer’s Disease.
Tweet card summary image
nejm.org
Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt surgery...
1
2
8
@NINDSdirector
Walter J. Koroshetz
2 months
NINDS is thrilled to continue support for the ALLFTD study-working with NIA to build the tools and national infrastructure for future clinical trials in frontotemporal dementia (FTD) spectrum disorders. Learn more:
Tweet card summary image
allftd.org
1
1
1
@NINDSdirector
Walter J. Koroshetz
2 months
See this comprehensive review of the state of knowledge and research recommendations for Alzheimer’s Related Dementias. Thanks to the many contributors to the 2025 ADRD Summit. https://t.co/4bmm2L5SvD; https://t.co/ixyvpyMQXg
0
0
3
@NINDSdirector
Walter J. Koroshetz
3 months
#NIH has opened the search for the next Director of the National Institute of Mental Health (#NIMH). Clearly it is an opportunity of a lifetime to advance science that will enable effective prevention and treatment of mental illness for all. https://t.co/Vb38IW6P07
2
8
21
@NINDSdirector
Walter J. Koroshetz
3 months
Happy 15th anniversary to the National Intrepid Center of Excellence (NICoE). NICoE improves the lives of service members with traumatic brain injury and other invisible wounds of war through excellence in TBI clinical care, research, and education.
Tweet card summary image
health.mil
The NICoE is a Department of Defense organization and the senior member of Defense Intrepid Network for Traumatic Brain Injury and Brain Health. The NICoE is dedicated to improving the lives of...
2
0
7
@NINDSdirector
Walter J. Koroshetz
3 months
Releasing a stalled brain “brake” may jump-start myelin repair in #MultipleSclerosis. New #NIH-supported study findings from @CWRUSOM scientists point to new #RegenerativeMedicine strategies and hope for restoring function. Check out the paper in Cell:
Tweet card summary image
cell.com
Oligodendrocyte maturation is governed by an SOX6-dependent gene-melted chromatin state at multiple immaturity loci. Reducing SOX6 accelerates maturation, offering a potential strategy to regenerate...
0
0
10
@NINDSdirector
Walter J. Koroshetz
3 months
Years of data collection funded by NIH's NINDS and Department of Defense led to a more precise, data-driven classification of traumatic brain injury.
Tweet card summary image
nationalacademies.org
At a recent National Academies event, scientific experts, patient advocates, individuals with lived experience, and other stakeholders discussed the National Institute of Neurological Disorders and...
1
2
9
@NINDSdirector
Walter J. Koroshetz
3 months
Nice summary on the NIH BRAIN Initiative’s research on modulating circuit function to improve health - #Parkinsonsdisease, #Depression, Obsessive Compulsive Disorder, as well as #Epilepsy, severe chronic #Pain.
Tweet card summary image
nature.com
Nature - The next generation of deep-brain stimulation automatically corrects the precise brain waves that create symptoms of Parkinson’s disease. Can this approach target other conditions?
0
0
8
@NINDSdirector
Walter J. Koroshetz
3 months
Don’t find sex differences in the GWAS to account for female predominance in ME/CFS. Could be that females are more vulnerable, like males are in autism.
@NINDSdirector
Walter J. Koroshetz
3 months
Massive genetic association study of persons with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests genes expressed in the brain influence development of this disabling disorder.
2
0
5
@NINDSdirector
Walter J. Koroshetz
3 months
Massive genetic association study of persons with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests genes expressed in the brain influence development of this disabling disorder.
science.org
DNA analysis of more than 15,500 people with the debilitating condition identifies eight tentative “genetic signals”
1
3
9
@NINDSdirector
Walter J. Koroshetz
3 months
Massive genetic association study of persons with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests genes expressed in the brain influence development of this disabling disorder.
science.org
DNA analysis of more than 15,500 people with the debilitating condition identifies eight tentative “genetic signals”
1
3
9
@NINDSdirector
Walter J. Koroshetz
3 months
And special thanks to the thousands of people who volunteered to take part in NINDS research over the last 75 years. They are the true heroes of NINDS.
@NINDSdirector
Walter J. Koroshetz
3 months
HAPPY 75th BIRTHDAY NINDS. On August 15th 1950 President Truman signed Public Law 81-692, establishing the National Institute of Neurological Diseases and Blindness (NINDB).
0
3
15
@NINDSdirector
Walter J. Koroshetz
3 months
Thanks to all who dedicated their careers, time and effort over 75 years to advance the NINDS mission to understand how the nervous system works, and use that knowledge to reduce suffering due to neurological disorders.
@NINDSdirector
Walter J. Koroshetz
3 months
HAPPY 75th BIRTHDAY NINDS. On August 15th 1950 President Truman signed Public Law 81-692, establishing the National Institute of Neurological Diseases and Blindness (NINDB).
0
3
36
@NINDSdirector
Walter J. Koroshetz
3 months
HAPPY 75th BIRTHDAY NINDS. On August 15th 1950 President Truman signed Public Law 81-692, establishing the National Institute of Neurological Diseases and Blindness (NINDB).
0
0
11
@NINDSdirector
Walter J. Koroshetz
4 months
It's risky to study the brain without considering it's connections to rest of the body. Finding synuclein aggregates in skin and nerves to the gut has changed thinking about triggers for Parkinson's disease. Read the story.
@NIH_NINDS
NINDS
4 months
"Breakthrough Beneath the Skin" transforms neurological diagnosis and creates jobs nationwide! Our story follows the the Syn-One Test journey, a revolutionary skin biopsy for #ParkinsonsDisease and related disorders. Explore the full story: https://t.co/lZFYjogpwf #NINDS75
0
1
14
@NINDSdirector
Walter J. Koroshetz
4 months
U.S. Pointer study results @AAIC demonstrated value of exercise, healthy diet, cognitive and social activities on improving cognition in elderly. Good points to improve your Brain Health.
Tweet card summary image
alz.org
U.S. POINTER is a lifestyle intervention clinical trial to support brain health, improve cognition & speed progress in Alzheimer's and dementia research.
0
2
7
@NINDSdirector
Walter J. Koroshetz
4 months
Gene editing technology has tremendous potential to correct neurogenetic disorders. See this report from Harvard and Jackson Lab on correcting mutations in the Na+/K+ ATPase in mouse. These mutations cause alternating hemiplegia in children.
Tweet card summary image
cell.com
Prime editing and base editing in mouse models and human cells effectively correct mutations in a gene that causes a childhood neurodevelopmental disorder called alternating hemiplegia of childhood....
1
0
6